Dabigatran Etexilate 150 mg/1 (Dabigatran Etexilate CAPSULE, COATED PELLETS) 150 mg/1

Dabigatran Etexilate 150 mg capsules are an oral medication used to prevent blood clots. This anticoagulant is commonly prescribed for conditions like atrial fibrillation and post-surgery recovery.

Strength

150 mg/1

Pack Size

2 BLISTER PACK in 1 CARTON (0904-7255-10) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7255

Manufacturer / TM Owner

Major Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran Etexilate is primarily used to reduce the risk of blood clots and stroke in patients with atrial fibrillation. It is also prescribed to prevent deep vein thrombosis and pulmonary embolism after certain surgeries. This medication works by inhibiting thrombin, an enzyme crucial for blood clot formation. Patients often ask, 'What is Dabigatran Etexilate used for?' It is typically used for long-term management of conditions that require anticoagulation.

Side Effects

Common effects of Dabigatran Etexilate may include minor bleeding, such as nosebleeds or bruising. Some users report stomach discomfort or heartburn. Severe bleeding, though rare, can occur and requires immediate medical attention. Always consult a healthcare provider if unusual symptoms persist.

Precautions & Warnings

Handle Dabigatran Etexilate with care, as it can increase the risk of bleeding. Avoid activities that may cause injury while taking this medication. Inform your healthcare provider about any other medications you are taking, especially those that affect blood clotting. Store the capsules in a cool, dry place away from direct sunlight.

Avoid Interactions

Dabigatran Etexilate may interact with other blood-thinning medications, increasing the risk of bleeding. Alcohol can also enhance the effects of this medication, so it should be consumed with caution. Certain antacids and medications that affect liver enzymes may alter the effectiveness of Dabigatran Etexilate. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Dabigatran Etexilate is used to prevent blood clots and reduce the risk of stroke in conditions like atrial fibrillation.

Dabigatran Etexilate capsules should be taken orally, typically with water, as directed by a healthcare provider.

Common side effects include minor bleeding, stomach discomfort, and heartburn. Severe bleeding is rare but requires immediate medical attention.

Dabigatran Etexilate may interact with other blood-thinning medications and certain antacids. Always consult a healthcare provider before combining medications.

Store Dabigatran Etexilate capsules in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.